Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Granulomatous Disease, Chronic

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Granulomatous Disease, Chronic in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lewis, CJ1
Cobb, BA1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Granulomatous Disease, Chronic

ArticleYear
Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.
    European journal of immunology, 2011, Volume: 41, Issue:9

    Topics: Adaptive Immunity; Adoptive Transfer; Amidines; Animals; Antigen Presentation; Benzylamines; Cells,

2011